Clarus Wealth Advisors »

Blueprint Medicines shares owned by Clarus Wealth Advisors

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Clarus Wealth Advisors from 13F filings

Historical chart of Clarus Wealth Advisors investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Clarus Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Clarus Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $224k 2.5k 90.49
2023-12-31 $265k 3.3k 79.68

More positions owned by Clarus Wealth Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard World Mega Grwth Ind (MGK)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Apple (AAPL)
Pacer Fds Tr Emrg Mkt Cash (ECOW)
Select Sector Spdr Tr Technology (XLK)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core S&p Mcp Etf (IJH)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Growth Etf (VUG)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr S&p 400 Mdcp Val (MDYV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)

View all positions for Clarus Wealth Advisors

Top funds holding Blueprint Medicines

Vanguard Group
T. Rowe Price Associates
Wellington Management Company
William Blair Investment Management
Jpmorgan Chase & Co
Lord, Abbett & Co
Alliancebernstein
Brown Advisory Holdings Incorporated
Avidity Partners Management
Norges Bank Investment Management
Goldman Sachs Group
Charles Schwab Investment Management
Emerald Advisers
Point72 Asset Management
Bank of America Corporation

View all funds holding Blueprint Medicines